Get the latest news, insights, and market updates on PMI (Picard Medical, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City
TUCSON, Ariz., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced it will attend the Canaccord Genuity (CG) MedTech, Diagnostics and Digital Health & Services Forum to be held on November 20, 2025, in New York, NY. Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, Inc., Nov 12, 2025 - $PMI
Picard to Showcase its Total Artificial Heart at the Annual Meeting of the American Heart Association 2025
TUCSON, Ariz., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, today announced it will exhibit at the annual meeting of the American Heart Association (AHA) being held November 7th through 10th in New Orleans, Louisiana. At the annual meeting of the AHA, Picard will showcase its SynCardia™ Total Artificial Hea Nov 3, 2025 - $PMI
Picard Medical (PMI): Assessing Valuation After Share Expansion and Dilution Concerns Spark Sell-Off
Picard Medical (PMI) shares saw a steep drop after the company disclosed an expansion of its equity incentive plan, increasing the available shares to 18 million and adding warrants. This led to immediate concerns over shareholder dilution. See our latest analysis for Picard Medical. The dramatic 59.77% plunge in Picard Medical's share price over a single day put a spotlight on dilution risks. The company’s year-to-date share price return remains positive at 15.69%. Recent events such as the... Oct 25, 2025 - $PMI
Picard Issues Statement on Intraday Stock Price
TUCSON, Ariz., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, today announced that it is not aware of any undisclosed material change in the Company’s operations or financial condition, that would account for the recent volatility in its stock price. The Company remains focused on executing its strategic and Oct 24, 2025 - $PMI
Perseverance Metals to Commence Trading on TSXV Under Symbol 'PMI' Following $8.2 Million Go-Public Financing
Vancouver, British Columbia--(Newsfile Corp. - October 13, 2025) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance", the "Company" or "PMI") is pleased to announce that its common shares will commence trading at the market open on Tuesday, October 14th on the TSX Venture Exchange (the "TSXV") under the ticker symbol "PMI".The listing follows the successful completion of the Company's oversubscribed go-public financings, which raised aggregate gross proceeds of approximately C$8.2 million... Oct 13, 2025 - $PMI
Perseverance Announces Conversion of Subscription Receipts and Satisfaction of the Lac Gayot Free Carry Right
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Perseverance Metals Inc. ("Perseverance" or the "Company") is pleased to announce that the Company has issued a total of 4,902,099 common shares and 2,451,027 common share purchase warrants ("Warrants") pursuant to the conversion of 4,902,099 subscription receipts of the Company issued on September 5, 2025. The net proceeds from the sale of the subscription receipts, being C$3,186,398, have also been released to the Company from. Oct 10, 2025 - $PMI
Perseverance to Commence Trading on the TSXV & Satisfies Escrow Release Conditions
Vancouver, British Columbia--(Newsfile Corp. - October 8, 2025) - Perseverance Metals Inc. ("Perseverance" or the "Company") is pleased to announce that its common shares have been approved for listing on the TSX Venture Exchange (the "TSXV"). The common shares are expected to commence trading under the ticker symbol "PMI" as of market open on October 14, 2025.The Company has also received a receipt for its final long form prospectus (the "Final Prospectus"), which was filed with the securities. Oct 8, 2025 - $PMI
J-Star Holding Names Sam Van as Chief Executive Officer
TAICHUNG CITY, Taiwan, Sept. 22, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare products, automobile parts, resin systems, and research and development services, today announced that Sam Van has been named Chief Executive Officer of J-Star, effective October 1. Mr. Van succeeds Jonathan Chiang, who Sep 22, 2025 - $PMI
Picard Advances Patent Protection for Fully Implantable Artificial Heart Technology
- Patent portfolio secures innovation for the future of heart replacement - TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, today announced the strengthening of its intellectual property portfolio with the recent grant of U.S. Patent No. 12,383,722 B2 covering systems and methods related to its Sep 22, 2025 - $PMI
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple